Stem Cell Transplantation For Severe Sclerosis Linked With Improved Long-term Survival
JAMA - Journal of the American Medical AssociationAmong patients with a severe, life-threatening type of sclerosis, treatment with hematopoietic stem cell transplantation (HSCT), compared to intravenous infusion of the chemotherapeutic drug cyclophosphamide, was associated with an increased treatment-related risk of death in the first year, but better long-term survival, according to a study in the June 25 issue of JAMA.